Oncotelic Therapeutics OTLC
OTC OTLC
$0.01 +0.00 (+0.00%)
At close: Nov 6, 2026 · 4:00 PM EST

Oncotelic Therapeutics (OTLC) Return on Capital Employed [ROCE] (2011 - 2026)

Updated

Oncotelic Therapeutics' Return on Capital Employed [ROCE] was -1.04% in Q2 2026, up 46.05 percentage points from -47.10% a year earlier.

Analysis

Oncotelic Therapeutics (OTLC) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Oncotelic Therapeutics came in at -1.66%, up 37.44 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now increased for four consecutive years, with a five-year change of +59.06 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -39.10% in FY2024 (+1.04 pp), -40.14% in FY2023 (+34.98 pp), -75.12% in FY2022 (+36.40 pp) and -111.52% in FY2021 (-50.80 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last seven quarters, with an average year-over-year change of +17.95 percentage points.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2023 (a gain of 143.66 percentage points); the worst was Q1 2022 (a drop of 109.61 percentage points).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,246.67 Bn 1,220.29 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 674.78 Bn 594.65 Bn 17.30 Bn 17.52%
3 AbbVie 517.28 Bn 485.29 Bn 13.12 Bn 21.60%
4 Merck 363.83 Bn 326.77 Bn 13.19 Bn 5.33%
5 Novartis Ag 315.42 Bn 288.66 Bn - -
6 Astrazeneca 292.85 Bn 266.74 Bn 13.26 Bn 9.91%
7 Amgen 250.38 Bn 202.03 Bn 7.58 Bn 17.37%
8 Gilead Sciences 209.70 Bn 184.81 Bn 6.73 Bn -6.15%
9 Pfizer 167.07 Bn 114.42 Bn 12.56 Bn 11.32%
10 Oncotelic Therapeutics 6.49 Mn 5.66 Mn - -1.52%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.04%
Dec 31, 2025 -1.66%
Sep 30, 2025 -9.40%
Jun 30, 2025 -47.10%
Mar 31, 2025 -48.83%
Dec 31, 2024 -47.49%
Sep 30, 2024 -30.48%
Jun 30, 2024 -2.64%
Mar 31, 2024 -48.86%
Dec 31, 2023 -49.33%
Sep 30, 2023 -85.74%
Jun 30, 2023 -78.34%
Mar 31, 2023 -30.52%
Dec 31, 2022 -45.74%
Sep 30, 2022 -27.84%
Jun 30, 2022 -50.63%
Mar 31, 2022 -174.18%
Dec 31, 2021 -114.84%
Sep 30, 2021 -126.51%
Jun 30, 2021 -110.56%
API Access

Oncotelic Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEY